The Role of Interleukin-20 in Paclitaxel-Associated Peripheral Neuropathy in Non-Metastatic Breast Cancer Patients Receiving Chemotherapy

The Role of Interleukin-20 in Paclitaxel-Associated Peripheral Neuropathy in Non-Metastatic Breast Cancer Patients Receiving Chemotherapy

Introduction: This study investigated the relationship between serum interleukin-20 (IL-20) levels and paclitaxel-associated neuropathy in patients with non-metastatic breast cancer. Paclitaxel-induced peripheral neuropathy (PIPN) is a significant side effect of paclitaxel chemotherapy, and the exac...

Full description

Bibliographic Details
Main Authors:	Kubilay Karaboyun, Eyyüp Çavdar, Yakup İriağaç, Ahsen Yılmaz, Aliye Çelikkol, Okan Avcı, Erdoğan Selçuk Şeber
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2023-11-01
Series:	İstanbul Medical Journal
Subjects:	paclitaxel peripheral neuropathy breast cancer il-20 qlq-cipn20
Online Access:	http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-role-of-nterleukin-20-in-paclitaxel-associated/63647

Similar Items

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01)

Longitudinal RNA Sequencing of Skin and DRG Neurons in Mice with Paclitaxel-Induced Peripheral Neuropathy
by: Anthony M. Cirrincione, et al.
Published: (2022-05-01)

Skin Extracellular Matrix Breakdown Following Paclitaxel Therapy in Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Nathan P. Staff, et al.
Published: (2023-08-01)

Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study
by: Eyyup Cavdar, et al.
Published: (2022-08-01)

Use of Complementary Therapy in Lung Cancer Patients Treated with Chemotherapy and its Effect on Survival: A Cross-sectional Study
by: Eyyup Cavdar, et al.
Published: (2023-01-01)

Effects of COVID-19 Pandemic on Diagnosis-treatment Process in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
by: Eyyüp ÇAVDAR, et al.
Published: (2021-12-01)

Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice
by: Aryah Basu, et al.
Published: (2024-01-01)

Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
by: Rozalyn L. Rodwin, et al.
Published: (2022-03-01)

Metformin inhibits spontaneous excitatory postsynaptic currents in spinal dorsal cord neurons from paclitaxel-treated rats
by: Ting-Ting Liu, et al.
Published: (2023-05-01)

Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01)

Glycyrrhizic Acid Prevents Paclitaxel-Induced Neuropathy via Inhibition of OATP-Mediated Neuronal Uptake
by: Ines Klein, et al.
Published: (2023-04-01)

A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy
by: Yusuke Fukuda, et al.
Published: (2017-08-01)

<i>Phlomidis Radix</i> Extract Alleviates Paclitaxel-Induced Neuropathic Pain by Modulating Spinal TRPV1 in Mice
by: Keun-Tae Park, et al.
Published: (2023-11-01)

The Role of NMNAT2/SARM1 in Neuropathy Development
by: Olga Tarasiuk, et al.
Published: (2024-01-01)

The effect of Sargassum glaucescens from the Persian gulf on neuropathy pain induced by paclitaxel in mice
by: Afsaneh Yegdaneh, et al.
Published: (2020-01-01)

Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01)

Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms
by: L. Brett Whalen, et al.
Published: (2022-02-01)

Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis
by: Megan Crichton, et al.
Published: (2022-06-01)

Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy
by: Jennifer M. Brazill, et al.
Published: (2018-06-01)

Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
by: Khoshnevisan Alireza, et al.
Published: (2012-05-01)

Paclitaxel Inhibits KCNQ Channels in Primary Sensory Neurons to Initiate the Development of Painful Peripheral Neuropathy
by: Zizhen Wu, et al.
Published: (2022-12-01)

The Antinociceptive Responses of MTDZ to Paclitaxel−Induced Peripheral Neuropathy and Acute Nociception in Mice: Behavioral, Pharmacological, and Biochemical Approaches
by: Ketlyn P. da Motta, et al.
Published: (2023-08-01)

A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice
by: Martial Caillaud, et al.
Published: (2020-12-01)

Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice
by: Urszula O. Warncke, et al.
Published: (2021-07-01)

Predictive Factors of Complete Tumor Response to First Line Chemotherapy in Patients with Extensive-stage Small Cell Lung Cancer
by: Eyyüp Çavdar, et al.
Published: (2022-06-01)

Protective effects of oxytocin and progesterone on paclitaxel-induced neuropathy in rats
by: Mehmet Ekici, et al.
Published: (2021-01-01)

The Therapeutic Potential of Monocyte/Macrophage Manipulation in the Treatment of Chemotherapy-Induced Painful Neuropathy
by: Karli Montague, et al.
Published: (2017-11-01)

A review of movement disorders in chemotherapy-induced neurotoxicity
by: Allison B. Wang, et al.
Published: (2021-01-01)

TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In Vitro
by: Yesul Kim, et al.
Published: (2022-02-01)

Anti-oxidant profile of Divya-Peedantak-Vati abates paclitaxel-induced hyperalgesia and allodynia in CD-1 mice model of neuropathic pain
by: Acharya Balkrishna, et al.
Published: (2022-05-01)

Management of paclitaxel-induced neurotoxicity
by: Manisha Bhutani, et al.
Published: (2011-12-01)

Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
by: Takehiro Kawashiri, et al.
Published: (2021-08-01)

Exercise for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials
by: Yingjie Huang, et al.
Published: (2024-01-01)

Genetic variations that influence paclitaxel pharmacokinetics and intracellular effects that may contribute to chemotherapy-induced neuropathy: A narrative review
by: Ken B. Johnson, et al.
Published: (2023-05-01)

Corrigendum: Exercise for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials
by: Yingjie Huang, et al.
Published: (2024-03-01)

Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center
by: Florent Bienfait, et al.
Published: (2023-01-01)

Randomized clinical trial quantifying the effectiveness of a self-monitoring intervention in cancer patients with peripheral neuropathy: A quantitative study
by: Kiyoko Kanda, et al.
Published: (2023-04-01)

Risk factors of paclitaxel-induced peripheral neuropathy in patients with breast cancer: a prospective cohort study
by: Sun Lixian, et al.
Published: (2024-03-01)

Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel
by: Praful Pandey, et al.
Published: (2023-02-01)

Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives
by: Katarzyna Szklener, et al.
Published: (2023-03-01)